<?xml version='1.0' encoding='utf-8'?>
<document id="22377533"><sentence text="Cholesterol level influences opioid signaling in cell models and analgesia in mice and humans."><entity charOffset="0-11" id="DDI-PubMed.22377533.s1.e0" text="Cholesterol" /><entity charOffset="29-35" id="DDI-PubMed.22377533.s1.e1" text="opioid" /><pair ddi="false" e1="DDI-PubMed.22377533.s1.e0" e2="DDI-PubMed.22377533.s1.e0" /><pair ddi="false" e1="DDI-PubMed.22377533.s1.e0" e2="DDI-PubMed.22377533.s1.e1" /></sentence><sentence text="Cholesterol regulates the signaling of µ-opioid receptor in cell models, but it has not been demonstrated in mice or humans"><entity charOffset="0-11" id="DDI-PubMed.22377533.s2.e0" text="Cholesterol" /></sentence><sentence text=" Whether cholesterol regulates the signaling by mechanisms other than supporting the entirety of lipid raft microdomains is still unknown"><entity charOffset="9-20" id="DDI-PubMed.22377533.s3.e0" text="cholesterol" /></sentence><sentence text=" By modulating cholesterol-enriched lipid raft microdomains and/or total cellular cholesterol contents in human embryonic kidney cells stably expressing µ-opioid receptor, we concluded that cholesterol stabilized opioid signaling both by supporting the lipid raft's entirety and by facilitating G protein coupling"><entity charOffset="15-26" id="DDI-PubMed.22377533.s4.e0" text="cholesterol" /><entity charOffset="82-93" id="DDI-PubMed.22377533.s4.e1" text="cholesterol" /><entity charOffset="190-201" id="DDI-PubMed.22377533.s4.e2" text="cholesterol" /><pair ddi="false" e1="DDI-PubMed.22377533.s4.e0" e2="DDI-PubMed.22377533.s4.e0" /><pair ddi="false" e1="DDI-PubMed.22377533.s4.e0" e2="DDI-PubMed.22377533.s4.e1" /><pair ddi="false" e1="DDI-PubMed.22377533.s4.e0" e2="DDI-PubMed.22377533.s4.e2" /><pair ddi="false" e1="DDI-PubMed.22377533.s4.e1" e2="DDI-PubMed.22377533.s4.e1" /><pair ddi="false" e1="DDI-PubMed.22377533.s4.e1" e2="DDI-PubMed.22377533.s4.e2" /></sentence><sentence text=" Similar phenomena were observed in the primary rat hippocampal neurons" /><sentence text=" In addition, reducing the brain cholesterol level with simvastatin impaired the analgesic effect of opioids in mice, whereas the opioid analgesic effect was enhanced in mice fed a high-cholesterol diet"><entity charOffset="33-44" id="DDI-PubMed.22377533.s6.e0" text="cholesterol" /><entity charOffset="56-67" id="DDI-PubMed.22377533.s6.e1" text="simvastatin" /><entity charOffset="130-136" id="DDI-PubMed.22377533.s6.e2" text="opioid" /><entity charOffset="186-197" id="DDI-PubMed.22377533.s6.e3" text="cholesterol" /><pair ddi="false" e1="DDI-PubMed.22377533.s6.e0" e2="DDI-PubMed.22377533.s6.e0" /><pair ddi="false" e1="DDI-PubMed.22377533.s6.e0" e2="DDI-PubMed.22377533.s6.e1" /><pair ddi="false" e1="DDI-PubMed.22377533.s6.e0" e2="DDI-PubMed.22377533.s6.e2" /><pair ddi="false" e1="DDI-PubMed.22377533.s6.e0" e2="DDI-PubMed.22377533.s6.e3" /><pair ddi="false" e1="DDI-PubMed.22377533.s6.e1" e2="DDI-PubMed.22377533.s6.e1" /><pair ddi="false" e1="DDI-PubMed.22377533.s6.e1" e2="DDI-PubMed.22377533.s6.e2" /><pair ddi="false" e1="DDI-PubMed.22377533.s6.e1" e2="DDI-PubMed.22377533.s6.e3" /><pair ddi="false" e1="DDI-PubMed.22377533.s6.e2" e2="DDI-PubMed.22377533.s6.e2" /><pair ddi="false" e1="DDI-PubMed.22377533.s6.e2" e2="DDI-PubMed.22377533.s6.e3" /></sentence><sentence text=" Furthermore, when the records of patients were analyzed, an inverse correlation between cholesterol levels and fentanyl doses used for anesthesia was identified, which suggested the mechanisms above could also be applicable to humans"><entity charOffset="89-100" id="DDI-PubMed.22377533.s7.e0" text="cholesterol" /><entity charOffset="112-120" id="DDI-PubMed.22377533.s7.e1" text="fentanyl" /><pair ddi="false" e1="DDI-PubMed.22377533.s7.e0" e2="DDI-PubMed.22377533.s7.e0" /><pair ddi="false" e1="DDI-PubMed.22377533.s7.e0" e2="DDI-PubMed.22377533.s7.e1" /></sentence><sentence text=" Our results identified the interaction between opioids and cholesterol, which should be considered in clinics as a probable route for drug-drug interaction"><entity charOffset="60-71" id="DDI-PubMed.22377533.s8.e0" text="cholesterol" /></sentence><sentence text=" Our studies also suggested that a low cholesterol level could lead to clinical issues, such as the observed impairment in opioid functions"><entity charOffset="39-50" id="DDI-PubMed.22377533.s9.e0" text="cholesterol" /><entity charOffset="123-129" id="DDI-PubMed.22377533.s9.e1" text="opioid" /><pair ddi="false" e1="DDI-PubMed.22377533.s9.e0" e2="DDI-PubMed.22377533.s9.e0" /><pair ddi="false" e1="DDI-PubMed.22377533.s9.e0" e2="DDI-PubMed.22377533.s9.e1" /></sentence><sentence text="" /></document>